Rabies Post-exposure Prophylaxis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Rabies Post-exposure Prophylaxis trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07327307

Real World Evidence Study of SYN023 in Children Exposed to Rabies

This observational study is an open-label, prospective, multi-center design. The goal is to evaluate the long-term clinical survival outcomes at 3 months and 1…

China232 participantsStarted 2025-08-02Updated 2026-04-23

All recent trials (31 shown)

CompletedPhase 2

NCT03961555

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

This is a Phase 2b, double blinded, randomized study of SYN023 compared to HyperRab® (a licensed Rabies immune globulin from human sources, HRIG) for the preven…

United States, Philippines448 participantsStarted 2019-09-03Updated 2026-06-29

Treatment: SYN023, HRIG (HyperRab)

Active — Not RecruitingNot Applicable

NCT07624461

Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang

The objective of this real-world, prospective observational study is to evaluate the clinical effectiveness of zamerovimab and mazorelvimab injection (a human r…

China80 participantsStarted 2025-06-06

Rabies Post-exposure Prophylaxis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Real World Evidence Study of SYN023 in Children Exposed to Rabies

All recent trials (31 shown)

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Real World Evidence Study of SYN023 in Children Exposed to Rabies

All recent trials (31 shown)

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang

Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.

SYN023 With Rabies Vaccine in Healthy Pediatric Subjects

Survey of Human Rabies Immune Globulin Safety in Children

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophyl…

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophyl…

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Study to Evaluate GR1801's Efficacy and Safety

A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried

A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vacc…

Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally

A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety

Immunity Persistence After Abridged Intradermal Rabies PEP

Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia

Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project

Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen

Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exp…

Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects